Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Photoelectric conversion apparatus
Reduced sorbent utilization for circulating dry scrubbers
Pharmaceutical combination of pazopanib and topotecan to treat neuroblastoma, osteosarcoma, and rhabdomyosarcoma in a human
Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof
Method and devices for handling access privileges
Systems and/or methods for using air/wind power to charge/re-charge vehicle batteries
Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs
  Randomly Featured Patents
Multilevel semiconductor memory, write/read method thereto/therefrom and storage medium storing write/read program
Portable optical information reading apparatus
Remote object recognition
Remote sensing and actuation of fluid in cranial implants
System and method for sealing battery separator
Bacterial product from marine origin, useful for preventing the macro and micro biofouling caused by macroalgae and marine invertebrates
Substrate holder and plating apparatus
Charged particle beam reflector device and electron microscope
Portable electronic device comprising several contact-free integrated circuits
Polishing pads and methods relating thereto